drugset / Trial / NCT05215873

Induction of Labor in Pregnant Women With Prelabor Rupture of Membranes - Oxytocin or Misoprostol

NCT05215873

Phase 4 Completed 200 enrolled Ain Shams Maternity Hospital
RandomizedParallel-groupOpen-labelTreatment

Summary

The aim of study is to compare the efficacy and safety of oral misoprostol versus oxytocin in induction of labor in pregnant women with prelabor rupture of membranes at term.

Timeline

Start
2021-02-01
Primary completion
2022-01-15
Completion
2022-05-16

Drugs

EvaluationDrugModalityDoseRoute
Comparator Misoprostol Other / unclassified 25 ug Oral
Comparator Oxytocin Peptide 3 iu